Group 1A: Metastatic Breast Cancer; ER+; Biomarkers; Liquid Biopsy; Novel Drug

Poster #P4-10-28: Efficacy, safety and biomarker results of AC699, a chimeric estrogen receptor degrader, in patients with advanced or metastatic breast cancer

Poster #P1-05-19: Circulating Tumor DNA as a Prognostic Biomarker for CDK 4/6 Inhibitor Therapy in Metastatic Breast Cancer